“Long-term Efficacy and Safety of Brodalumab in Patients With or Without History of Psoriatic Arthritis: Analysis of Two Phase 3 Psoriasis Studies”, J of Skin, vol. 3, p. S21, Nov. 2019, doi: 10.25251/skin.3.supp.21.